SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC. v. MYLAN PHARMACEUTICALS, INC ., TEVA PHARMACEUTICALS USA, INC., and AKORN, INC. | Association for Accessible Medicines
AAM Amicus Brief

SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC. v. MYLAN PHARMACEUTICALS, INC ., TEVA PHARMACEUTICALS USA, INC., and AKORN, INC.

Friday the Association for Accessible Medicines filed an amicus brief in the U.S. Court of Appeals for the Federal Circuit calling on the court to reject gamesmanship of the patent system which keeps prescription drug prices high for patients. In this case, Allergan Inc. has transferred its patents to the St. Regis Mohawk Native American Tribe with the intent to use the Tribe’s sovereign immunity to evade review of the drug company’s patents. AAM is joining with a diverse range of groups, including America’s Health Insurance Plans, in opposing this abuse of the patent system.

View Brief

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.